A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.

NCT02072824 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Onset Seizures

Interventions

DRUG: Pregabalin Dose Level 1
DRUG: Pregabalin Dose Level 2
DRUG: Placebo

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.